| Financial Year |
March 31 2022 |
| Monetary Funds |
35,743,246.69 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
9,653,502.30 |
| Advances to Suppliers |
1,933,219.96 |
| Other Receivables |
17,745,489.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,283,482.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
66,358,940.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
11,082,664.89 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,122,053.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,833.33 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
59,600.00 |
| Sub-Total of Non-Current Assets |
36,380,151.99 |
| Total Assets |
102,739,092.57 |
| Short-Term Loans |
10,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,919,890.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,303,609.59 |
| Taxes Payable |
37,580,251.56 |
| Interest Payable |
155,054.80 |
| Dividend Payable |
135,701.80 |
| Other payables |
41,443,265.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
97,247,016.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
200,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
200,000.00 |
| Total Liabilities |
97,447,016.92 |
| Paid-In Capital(Or Share Stock) |
508,837,238.00 |
| Capital Surplus |
137,083,963.47 |
| Surplus Reserve |
25,187,220.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-597,098,708.99 |
| Minority Stockholder's Interest |
1,282,362.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,009,712.86 |
| Owner's Equity（Stockholder's Equity） |
5,292,075.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
102,739,092.57 |
